Aspirin-free strategies: A framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention

Davide Cao, Usman Baber, Roxana Mehran

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Access to Document

@article{1e2b7f60bb1e4f5294c78bf776a069e3,

title = "Aspirin-free strategies: A framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention",

author = "Davide Cao and Usman Baber and Roxana Mehran",

note = "Funding Information: The TWILIGHT trial was supported by an investigator-initiated grant from AstraZeneca.",

year = "2021",

month = jul,

day = "14",

doi = "10.1093/eurheartj/ehab041",

language = "English",

volume = "42",

pages = "2710--2711",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "27",

}

TY - JOUR

T1 - Aspirin-free strategies

T2 - A framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention

AU - Cao, Davide

AU - Baber, Usman

AU - Mehran, Roxana

N1 - Funding Information: The TWILIGHT trial was supported by an investigator-initiated grant from AstraZeneca.

PY - 2021/7/14

Y1 - 2021/7/14

UR - http://www.scopus.com/inward/record.url?scp=85112125137&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehab041

DO - 10.1093/eurheartj/ehab041

M3 - Comment/debate

C2 - 33615365

AN - SCOPUS:85112125137

SN - 0195-668X

VL - 42

SP - 2710

EP - 2711

JO - European Heart Journal

JF - European Heart Journal

IS - 27

ER -